Free Trial

Adagio Medical (ADGM) Competitors

Adagio Medical logo
$1.53 +0.18 (+13.33%)
Closing price 07/2/2025 03:59 PM Eastern
Extended Trading
$1.48 -0.05 (-3.27%)
As of 04:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ADGM vs. NPAB, AEAE, DYCQ, PORT, CSLM, AFJK, BRRR, SWSS, MITA, and CLPR

Should you be buying Adagio Medical stock or one of its competitors? The main competitors of Adagio Medical include New Providence Acquisition Corp. II (NPAB), AltEnergy Acquisition (AEAE), DT Cloud Acquisition (DYCQ), Southport Acquisition (PORT), CSLM Acquisition (CSLM), Aimei Health Technology (AFJK), CoinShares Valkyrie Bitcoin Fund (BRRR), Clean Energy Special Situations (SWSS), Coliseum Acquisition (MITA), and Clipper Realty (CLPR). These companies are all part of the "trading" industry.

Adagio Medical vs. Its Competitors

New Providence Acquisition Corp. II (NASDAQ:NPAB) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

New Providence Acquisition Corp. II has higher earnings, but lower revenue than Adagio Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
New Providence Acquisition Corp. IIN/AN/AN/AN/AN/A
Adagio Medical$600K39.22-$75.04MN/AN/A

48.1% of Adagio Medical shares are held by institutional investors. 90.0% of New Providence Acquisition Corp. II shares are held by insiders. Comparatively, 53.5% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

New Providence Acquisition Corp. II's return on equity of 0.00% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
New Providence Acquisition Corp. IIN/A N/A N/A
Adagio Medical N/A -274.60%-151.76%

New Providence Acquisition Corp. II has a beta of 0.08, meaning that its stock price is 92% less volatile than the S&P 500. Comparatively, Adagio Medical has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500.

In the previous week, Adagio Medical had 1 more articles in the media than New Providence Acquisition Corp. II. MarketBeat recorded 1 mentions for Adagio Medical and 0 mentions for New Providence Acquisition Corp. II. Adagio Medical's average media sentiment score of 0.94 beat New Providence Acquisition Corp. II's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the news media.

Company Overall Sentiment
New Providence Acquisition Corp. II Neutral
Adagio Medical Positive

Summary

Adagio Medical beats New Providence Acquisition Corp. II on 5 of the 8 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADGM and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADGM vs. The Competition

MetricAdagio MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$20.76M$6.89B$5.54B$8.87B
Dividend YieldN/A1.16%5.39%4.10%
P/E RatioN/A26.5426.1719.90
Price / Sales39.2295.96413.55113.66
Price / CashN/A21.0136.1356.90
Price / Book1.174.718.025.38
Net Income-$75.04M$173.18M$3.15B$248.50M
7 Day Performance21.82%1.27%1.48%2.06%
1 Month Performance34.21%-0.32%3.66%4.86%
1 Year PerformanceN/A25.79%34.68%20.24%

Adagio Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADGM
Adagio Medical
N/A$1.53
+13.3%
N/AN/A$20.76M$600K0.0087
NPAB
New Providence Acquisition Corp. II
N/A$10.90
flat
N/AN/A$75.56MN/A0.003
AEAE
AltEnergy Acquisition
N/A$11.62
flat
N/AN/A$75.39MN/A0.003
DYCQ
DT Cloud Acquisition
N/A$10.78
-0.2%
N/A+6.6%$72.97MN/A0.00N/A
PORT
Southport Acquisition
N/A$12.00
flat
N/A+6.5%$69.46MN/A0.002,021News Coverage
CSLM
CSLM Acquisition
N/A$11.27
-6.1%
N/A+0.3%$68.92MN/A0.00N/ANews Coverage
Gap Down
AFJK
Aimei Health Technology
N/A$11.17
-0.1%
N/A+6.8%$68.36MN/A0.00N/A
BRRR
CoinShares Valkyrie Bitcoin Fund
N/A$29.92
+2.5%
N/A+77.1%$67.34MN/A0.00N/A
SWSS
Clean Energy Special Situations
N/A$10.70
flat
N/AN/A$67.31MN/A0.003High Trading Volume
MITA
Coliseum Acquisition
N/A$11.51
flat
N/AN/A$63.73MN/A0.002,021
CLPR
Clipper Realty
0.4427 of 5 stars
$3.93
+1.1%
N/A+6.6%$63.47M$148.77M-3.85140

Related Companies and Tools


This page (NASDAQ:ADGM) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners